-
1
-
-
0032489358
-
Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance
-
Kahn B.B. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 1998, 92:593-596.
-
(1998)
Cell
, vol.92
, pp. 593-596
-
-
Kahn, B.B.1
-
2
-
-
51249107750
-
Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
-
Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008, 51:1781-1789.
-
(2008)
Diabetologia
, vol.51
, pp. 1781-1789
-
-
Taylor, R.1
-
3
-
-
84886558949
-
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
-
Kawano Y., Cohen D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J. Gastroenterol. 2013, 48:434-441.
-
(2013)
J. Gastroenterol.
, vol.48
, pp. 434-441
-
-
Kawano, Y.1
Cohen, D.E.2
-
4
-
-
79959517565
-
Human fatty liver disease: old questions and new insights
-
Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
-
(2011)
Science
, vol.332
, pp. 1519-1523
-
-
Cohen, J.C.1
Horton, J.D.2
Hobbs, H.H.3
-
5
-
-
84856533216
-
Increased macrophage migration into adipose tissue in obese mice
-
Oh D.Y., Morinaga H., Talukdar S., Bae E.J., Olefsky J.M. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012, 61:346-354.
-
(2012)
Diabetes
, vol.61
, pp. 346-354
-
-
Oh, D.Y.1
Morinaga, H.2
Talukdar, S.3
Bae, E.J.4
Olefsky, J.M.5
-
6
-
-
77951146612
-
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis
-
Obstfeld A.E., Sugaru E., Thearle M., Francisco A.M., Gayet C., Ginsberg H.N., Ables E.V., Ferrante A.W. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 2010, 59:916-925.
-
(2010)
Diabetes
, vol.59
, pp. 916-925
-
-
Obstfeld, A.E.1
Sugaru, E.2
Thearle, M.3
Francisco, A.M.4
Gayet, C.5
Ginsberg, H.N.6
Ables, E.V.7
Ferrante, A.W.8
-
7
-
-
84874053088
-
The burden of liver disease in Europe: a review of available epidemiological data
-
Blachier M., Leleu H., Peck-Radosavljevic M., Valla D.C., Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 2013, 58:593-608.
-
(2013)
J. Hepatol.
, vol.58
, pp. 593-608
-
-
Blachier, M.1
Leleu, H.2
Peck-Radosavljevic, M.3
Valla, D.C.4
Roudot-Thoraval, F.5
-
8
-
-
84874045511
-
The origins and drivers of insulin resistance
-
Johnson A.M., Olefsky J.M. The origins and drivers of insulin resistance. Cell 2013, 152:673-684.
-
(2013)
Cell
, vol.152
, pp. 673-684
-
-
Johnson, A.M.1
Olefsky, J.M.2
-
9
-
-
77953868236
-
Lipid-induced insulin resistance: unravelling the mechanism
-
Samuel V.T., Petersen K.F., Shulman G.I. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010, 375:2267-2277.
-
(2010)
Lancet
, vol.375
, pp. 2267-2277
-
-
Samuel, V.T.1
Petersen, K.F.2
Shulman, G.I.3
-
10
-
-
84857861919
-
Mechanisms for insulin resistance: common threads and missing links
-
Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
-
(2012)
Cell
, vol.148
, pp. 852-871
-
-
Samuel, V.T.1
Shulman, G.I.2
-
11
-
-
80052840577
-
The metabolically benign and malignant fatty liver
-
Stefan N., Haring H.U. The metabolically benign and malignant fatty liver. Diabetes 2011, 60:2011-2017.
-
(2011)
Diabetes
, vol.60
, pp. 2011-2017
-
-
Stefan, N.1
Haring, H.U.2
-
13
-
-
84864710223
-
Selective insulin and leptin resistance in metabolic disorders
-
Konner A.C., Bruning J.C. Selective insulin and leptin resistance in metabolic disorders. Cell Metab. 2012, 16:144-152.
-
(2012)
Cell Metab.
, vol.16
, pp. 144-152
-
-
Konner, A.C.1
Bruning, J.C.2
-
14
-
-
0033636780
-
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
-
Shimomura I., Matsuda M., Hammer R.E., Bashmakov Y., Brown M.S., Goldstein J.L. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 2000, 6:77-86.
-
(2000)
Mol. Cell
, vol.6
, pp. 77-86
-
-
Shimomura, I.1
Matsuda, M.2
Hammer, R.E.3
Bashmakov, Y.4
Brown, M.S.5
Goldstein, J.L.6
-
15
-
-
38649110496
-
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis
-
Biddinger S.B., Hernandez-Ono A., Rask-Madsen C., Haas J.T., Aleman J.O., Suzuki R., Scapa E.F., Agarwal C., Carey M.C., Stephanopoulos G., Cohen D.E., King G.L., Ginsberg H.N., Kahn C.R. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008, 7:125-134.
-
(2008)
Cell Metab.
, vol.7
, pp. 125-134
-
-
Biddinger, S.B.1
Hernandez-Ono, A.2
Rask-Madsen, C.3
Haas, J.T.4
Aleman, J.O.5
Suzuki, R.6
Scapa, E.F.7
Agarwal, C.8
Carey, M.C.9
Stephanopoulos, G.10
Cohen, D.E.11
King, G.L.12
Ginsberg, H.N.13
Kahn, C.R.14
-
16
-
-
38649116056
-
Selective versus total insulin resistance: a pathogenic paradox
-
Brown M.S., Goldstein J.L. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 2008, 7:95-96.
-
(2008)
Cell Metab.
, vol.7
, pp. 95-96
-
-
Brown, M.S.1
Goldstein, J.L.2
-
17
-
-
77649264504
-
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
-
Li S., Brown M.S., Goldstein J.L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3441-3446.
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 3441-3446
-
-
Li, S.1
Brown, M.S.2
Goldstein, J.L.3
-
18
-
-
84862776887
-
NOX4 pathway as a source of selective insulin resistance and responsiveness
-
Wu X., Williams K.J. NOX4 pathway as a source of selective insulin resistance and responsiveness. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1236-1245.
-
(2012)
Arterioscler. Thromb. Vasc. Biol.
, vol.32
, pp. 1236-1245
-
-
Wu, X.1
Williams, K.J.2
-
19
-
-
84905381985
-
Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux
-
Otero Y.F., Stafford J.M., McGuinness O.P. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux. J. Biol. Chem. 2014, 289:20462-20469.
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 20462-20469
-
-
Otero, Y.F.1
Stafford, J.M.2
McGuinness, O.P.3
-
21
-
-
52049117445
-
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia
-
Doege H., Grimm D., Falcon A., Tsang B., Storm T.A., Xu H., Ortegon A.M., Kazantzis M., Kay M.A., Stahl A. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J. Biol. Chem. 2008, 283:22186-22192.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 22186-22192
-
-
Doege, H.1
Grimm, D.2
Falcon, A.3
Tsang, B.4
Storm, T.A.5
Xu, H.6
Ortegon, A.M.7
Kazantzis, M.8
Kay, M.A.9
Stahl, A.10
-
22
-
-
84857383028
-
Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass
-
Knebel B., Haas J., Hartwig S., Jacob S., Kollmer C., Nitzgen U., Muller-Wieland D., Kotzka J. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass. PLoS ONE 2012, 7:e31812.
-
(2012)
PLoS ONE
, vol.7
, pp. e31812
-
-
Knebel, B.1
Haas, J.2
Hartwig, S.3
Jacob, S.4
Kollmer, C.5
Nitzgen, U.6
Muller-Wieland, D.7
Kotzka, J.8
-
23
-
-
33749370739
-
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice
-
Dentin R., Benhamed F., Hainault I., Fauveau V., Foufelle F., Dyck J.R., Girard J., Postic C. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006, 55:2159-2170.
-
(2006)
Diabetes
, vol.55
, pp. 2159-2170
-
-
Dentin, R.1
Benhamed, F.2
Hainault, I.3
Fauveau, V.4
Foufelle, F.5
Dyck, J.R.6
Girard, J.7
Postic, C.8
-
24
-
-
79952211574
-
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation
-
Orellana-Gavalda J.M., Herrero L., Malandrino M.I., Paneda A., Sol Rodriguez-Pena M., Petry H., Asins G., Van Deventer S., Hegardt F.G., Serra D. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology 2011, 53:821-832.
-
(2011)
Hepatology
, vol.53
, pp. 821-832
-
-
Orellana-Gavalda, J.M.1
Herrero, L.2
Malandrino, M.I.3
Paneda, A.4
Sol Rodriguez-Pena, M.5
Petry, H.6
Asins, G.7
Van Deventer, S.8
Hegardt, F.G.9
Serra, D.10
-
25
-
-
69249154762
-
Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status
-
Pamir N., McMillen T.S., Kaiyala K.J., Schwartz M.W., LeBoeuf R.C. Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 2009, 150:4124-4134.
-
(2009)
Endocrinology
, vol.150
, pp. 4124-4134
-
-
Pamir, N.1
McMillen, T.S.2
Kaiyala, K.J.3
Schwartz, M.W.4
LeBoeuf, R.C.5
-
26
-
-
77952562217
-
Animal models of non-alcoholic steatohepatitis: of mice and man
-
Schattenberg J.M., Galle P.R. Animal models of non-alcoholic steatohepatitis: of mice and man. Dig. Dis. 2010, 28:247-254.
-
(2010)
Dig. Dis.
, vol.28
, pp. 247-254
-
-
Schattenberg, J.M.1
Galle, P.R.2
-
27
-
-
36849037401
-
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity
-
Koonen D.P., Jacobs R.L., Febbraio M., Young M.E., Soltys C.L., Ong H., Vance D.E., Dyck J.R. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56:2863-2871.
-
(2007)
Diabetes
, vol.56
, pp. 2863-2871
-
-
Koonen, D.P.1
Jacobs, R.L.2
Febbraio, M.3
Young, M.E.4
Soltys, C.L.5
Ong, H.6
Vance, D.E.7
Dyck, J.R.8
-
28
-
-
25444512015
-
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice
-
Grefhorst A., van Dijk T.H., Hammer A., van der Sluijs F.H., Havinga R., Havekes L.M., Romijn J.A., Groot P.H., Reijngoud D.J., Kuipers F. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E829-E838.
-
(2005)
Am. J. Physiol. Endocrinol. Metab.
, vol.289
, pp. E829-E838
-
-
Grefhorst, A.1
van Dijk, T.H.2
Hammer, A.3
van der Sluijs, F.H.4
Havinga, R.5
Havekes, L.M.6
Romijn, J.A.7
Groot, P.H.8
Reijngoud, D.J.9
Kuipers, F.10
-
29
-
-
45549089456
-
A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels
-
Stefanovic-Racic M., Perdomo G., Mantell B.S., Sipula I.J., Brown N.F., O'Doherty R.M. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E969-E977.
-
(2008)
Am. J. Physiol. Endocrinol. Metab.
, vol.294
, pp. E969-E977
-
-
Stefanovic-Racic, M.1
Perdomo, G.2
Mantell, B.S.3
Sipula, I.J.4
Brown, N.F.5
O'Doherty, R.M.6
-
30
-
-
79959550724
-
Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis
-
Wu J.W., Wang S.P., Alvarez F., Casavant S., Gauthier N., Abed L., Soni K.G., Yang G., Mitchell G.A. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology 2011, 54:122-132.
-
(2011)
Hepatology
, vol.54
, pp. 122-132
-
-
Wu, J.W.1
Wang, S.P.2
Alvarez, F.3
Casavant, S.4
Gauthier, N.5
Abed, L.6
Soni, K.G.7
Yang, G.8
Mitchell, G.A.9
-
31
-
-
84857366417
-
Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis
-
Monsenego J., Mansouri A., Akkaoui M., Lenoir V., Esnous C., Fauveau V., Tavernier V., Girard J., Prip-Buus C. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. J. Hepatol. 2012, 56:632-639.
-
(2012)
J. Hepatol.
, vol.56
, pp. 632-639
-
-
Monsenego, J.1
Mansouri, A.2
Akkaoui, M.3
Lenoir, V.4
Esnous, C.5
Fauveau, V.6
Tavernier, V.7
Girard, J.8
Prip-Buus, C.9
-
32
-
-
21044438592
-
Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance
-
Ibdah J.A., Perlegas P., Zhao Y., Angdisen J., Borgerink H., Shadoan M.K., Wagner J.D., Matern D., Rinaldo P., Cline J.M. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 2005, 128:1381-1390.
-
(2005)
Gastroenterology
, vol.128
, pp. 1381-1390
-
-
Ibdah, J.A.1
Perlegas, P.2
Zhao, Y.3
Angdisen, J.4
Borgerink, H.5
Shadoan, M.K.6
Wagner, J.D.7
Matern, D.8
Rinaldo, P.9
Cline, J.M.10
-
33
-
-
77952425688
-
Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model
-
Shindo N., Fujisawa T., Sugimoto K., Nojima K., Oze-Fukai A., Yoshikawa Y., Wang X., Yasuda O., Ikegami H., Rakugi H. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. J. Hepatol. 2010, 52:903-912.
-
(2010)
J. Hepatol.
, vol.52
, pp. 903-912
-
-
Shindo, N.1
Fujisawa, T.2
Sugimoto, K.3
Nojima, K.4
Oze-Fukai, A.5
Yoshikawa, Y.6
Wang, X.7
Yasuda, O.8
Ikegami, H.9
Rakugi, H.10
-
34
-
-
77956803815
-
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase
-
Falcon A., Doege H., Fluitt A., Tsang B., Watson N., Kay M.A., Stahl A. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E384-E393.
-
(2010)
Am. J. Physiol. Endocrinol. Metab.
, vol.299
, pp. E384-E393
-
-
Falcon, A.1
Doege, H.2
Fluitt, A.3
Tsang, B.4
Watson, N.5
Kay, M.A.6
Stahl, A.7
-
35
-
-
84860455885
-
The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance
-
Farese R.V., Zechner R., Newgard C.B., Walther T.C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 2012, 15:570-573.
-
(2012)
Cell Metab.
, vol.15
, pp. 570-573
-
-
Farese, R.V.1
Zechner, R.2
Newgard, C.B.3
Walther, T.C.4
-
36
-
-
84860482342
-
A ceramide-centric view of insulin resistance
-
Chavez J.A., Summers S.A. A ceramide-centric view of insulin resistance. Cell Metab. 2012, 15:585-594.
-
(2012)
Cell Metab.
, vol.15
, pp. 585-594
-
-
Chavez, J.A.1
Summers, S.A.2
-
37
-
-
0035914356
-
Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members
-
Cases S., Stone S.J., Zhou P., Yen E., Tow B., Lardizabal K.D., Voelker T., Farese R.V. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 2001, 276:38870-38876.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 38870-38876
-
-
Cases, S.1
Stone, S.J.2
Zhou, P.3
Yen, E.4
Tow, B.5
Lardizabal, K.D.6
Voelker, T.7
Farese, R.V.8
-
38
-
-
34547946930
-
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
-
Choi C.S., Savage D.B., Kulkarni A., Yu X.X., Liu Z.X., Morino K., Kim S., Distefano A., Samuel V.T., Neschen S., Zhang D., Wang A., Zhang X.M., Kahn M., Cline G.W., Pandey S.K., Geisler J.G., Bhanot S., Monia B.P., Shulman G.I. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J. Biol. Chem. 2007, 282:22678-22688.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 22678-22688
-
-
Choi, C.S.1
Savage, D.B.2
Kulkarni, A.3
Yu, X.X.4
Liu, Z.X.5
Morino, K.6
Kim, S.7
Distefano, A.8
Samuel, V.T.9
Neschen, S.10
Zhang, D.11
Wang, A.12
Zhang, X.M.13
Kahn, M.14
Cline, G.W.15
Pandey, S.K.16
Geisler, J.G.17
Bhanot, S.18
Monia, B.P.19
Shulman, G.I.20
more..
-
39
-
-
84878218164
-
Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress
-
Chan S.M., Sun R.Q., Zeng X.Y., Choong Z.H., Wang H., Watt M.J., Ye J.M. Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 2013, 62:2095-2105.
-
(2013)
Diabetes
, vol.62
, pp. 2095-2105
-
-
Chan, S.M.1
Sun, R.Q.2
Zeng, X.Y.3
Choong, Z.H.4
Wang, H.5
Watt, M.J.6
Ye, J.M.7
-
40
-
-
34347235098
-
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
-
Monetti M., Levin M.C., Watt M.J., Sajan M.P., Marmor S., Hubbard B.K., Stevens R.D., Bain J.R., Newgard C.B., S. Farese R.V., Hevener A.L., Farese R.V. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 2007, 6:69-78.
-
(2007)
Cell Metab.
, vol.6
, pp. 69-78
-
-
Monetti, M.1
Levin, M.C.2
Watt, M.J.3
Sajan, M.P.4
Marmor, S.5
Hubbard, B.K.6
Stevens, R.D.7
Bain, J.R.8
Newgard, C.B.9
Farese, R.V.10
Hevener, A.L.11
Farese, R.V.12
-
41
-
-
53149101726
-
Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice
-
Minehira K., Young S.G., Villanueva C.J., Yetukuri L., Oresic M., Hellerstein M.K., Farese R.V., Horton J.D., Preitner F., Thorens B., Tappy L. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J. Lipid Res. 2008, 49:2038-2044.
-
(2008)
J. Lipid Res.
, vol.49
, pp. 2038-2044
-
-
Minehira, K.1
Young, S.G.2
Villanueva, C.J.3
Yetukuri, L.4
Oresic, M.5
Hellerstein, M.K.6
Farese, R.V.7
Horton, J.D.8
Preitner, F.9
Thorens, B.10
Tappy, L.11
-
42
-
-
78149346457
-
CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance
-
Brown J.M., Betters J.L., Lord C., Ma Y., Han X., Yang K., Alger H.M., Melchior J., Sawyer J., Shah R., Wilson M.D., Liu X., Graham M.J., Lee R., Crooke R., Shulman G.I., Xue B., Shi H., Yu L. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J. Lipid Res. 2010, 51:3306-3315.
-
(2010)
J. Lipid Res.
, vol.51
, pp. 3306-3315
-
-
Brown, J.M.1
Betters, J.L.2
Lord, C.3
Ma, Y.4
Han, X.5
Yang, K.6
Alger, H.M.7
Melchior, J.8
Sawyer, J.9
Shah, R.10
Wilson, M.D.11
Liu, X.12
Graham, M.J.13
Lee, R.14
Crooke, R.15
Shulman, G.I.16
Xue, B.17
Shi, H.18
Yu, L.19
-
43
-
-
84863622674
-
The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver
-
van der Veen J.N., Lingrell S., Vance D.E. The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver. J. Biol. Chem. 2012, 287:23418-23426.
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 23418-23426
-
-
van der Veen, J.N.1
Lingrell, S.2
Vance, D.E.3
-
44
-
-
84884987653
-
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis
-
Martinez-Una M., Varela-Rey M., Cano A., Fernandez-Ares L., Beraza N., Aurrekoetxea I., Martinez-Arranz I., Garcia-Rodriguez J.L., Buque X., Mestre D., Luka Z., Wagner C., Alonso C., Finnell R.H., Lu S.C., Martinez-Chantar M.L., Aspichueta P., Mato J.M. Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology 2013, 58:1296-1305.
-
(2013)
Hepatology
, vol.58
, pp. 1296-1305
-
-
Martinez-Una, M.1
Varela-Rey, M.2
Cano, A.3
Fernandez-Ares, L.4
Beraza, N.5
Aurrekoetxea, I.6
Martinez-Arranz, I.7
Garcia-Rodriguez, J.L.8
Buque, X.9
Mestre, D.10
Luka, Z.11
Wagner, C.12
Alonso, C.13
Finnell, R.H.14
Lu, S.C.15
Martinez-Chantar, M.L.16
Aspichueta, P.17
Mato, J.M.18
-
45
-
-
84879125074
-
Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect
-
Rector R.S., Morris E.M., Ridenhour S., Meers G.M., Hsu F.F., Turk J., Ibdah J.A. Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology 2013, 57:2213-2223.
-
(2013)
Hepatology
, vol.57
, pp. 2213-2223
-
-
Rector, R.S.1
Morris, E.M.2
Ridenhour, S.3
Meers, G.M.4
Hsu, F.F.5
Turk, J.6
Ibdah, J.A.7
-
46
-
-
84861809881
-
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
-
Benhamed F., Denechaud P.D., Lemoine M., Robichon C., Moldes M., Bertrand-Michel J., Ratziu V., Serfaty L., Housset C., Capeau J., Girard J., Guillou H., Postic C. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 2012, 122:2176-2194.
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 2176-2194
-
-
Benhamed, F.1
Denechaud, P.D.2
Lemoine, M.3
Robichon, C.4
Moldes, M.5
Bertrand-Michel, J.6
Ratziu, V.7
Serfaty, L.8
Housset, C.9
Capeau, J.10
Girard, J.11
Guillou, H.12
Postic, C.13
-
47
-
-
79954996869
-
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
-
Jornayvaz F.R., Birkenfeld A.L., Jurczak M.J., Kanda S., Guigni B.A., Jiang D.C., Zhang D., Lee H.Y., Samuel V.T., Shulman G.I. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5748-5752.
-
(2011)
Proc. Natl. Acad. Sci. U. S. A.
, vol.108
, pp. 5748-5752
-
-
Jornayvaz, F.R.1
Birkenfeld, A.L.2
Jurczak, M.J.3
Kanda, S.4
Guigni, B.A.5
Jiang, D.C.6
Zhang, D.7
Lee, H.Y.8
Samuel, V.T.9
Shulman, G.I.10
-
48
-
-
79953787445
-
Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice
-
Turpin S.M., Hoy A.J., Brown R.D., Rudaz C.G., Honeyman J., Matzaris M., Watt M.J. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 2011, 54:146-156.
-
(2011)
Diabetologia
, vol.54
, pp. 146-156
-
-
Turpin, S.M.1
Hoy, A.J.2
Brown, R.D.3
Rudaz, C.G.4
Honeyman, J.5
Matzaris, M.6
Watt, M.J.7
-
49
-
-
0023028208
-
Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes
-
Haring H., Kirsch D., Obermaier B., Ermel B., Machicao F. Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. J. Biol. Chem. 1986, 261:3869-3875.
-
(1986)
J. Biol. Chem.
, vol.261
, pp. 3869-3875
-
-
Haring, H.1
Kirsch, D.2
Obermaier, B.3
Ermel, B.4
Machicao, F.5
-
50
-
-
0025292249
-
Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats
-
Karasik A., Rothenberg P.L., Yamada K., White M.F., Kahn C.R. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. J. Biol. Chem. 1990, 265:10226-10231.
-
(1990)
J. Biol. Chem.
, vol.265
, pp. 10226-10231
-
-
Karasik, A.1
Rothenberg, P.L.2
Yamada, K.3
White, M.F.4
Kahn, C.R.5
-
51
-
-
0021068997
-
Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C
-
Jacobs S., Sahyoun N.E., Saltiel A.R., Cuatrecasas P. Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:6211-6213.
-
(1983)
Proc. Natl. Acad. Sci. U. S. A.
, vol.80
, pp. 6211-6213
-
-
Jacobs, S.1
Sahyoun, N.E.2
Saltiel, A.R.3
Cuatrecasas, P.4
-
52
-
-
0038532298
-
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids
-
Chavez J.A., Knotts T.A., Wang L.P., Li G., Dobrowsky R.T., Florant G.L., Summers S.A. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 2003, 278:10297-10303.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 10297-10303
-
-
Chavez, J.A.1
Knotts, T.A.2
Wang, L.P.3
Li, G.4
Dobrowsky, R.T.5
Florant, G.L.6
Summers, S.A.7
-
53
-
-
84864292975
-
Role of ceramides in nonalcoholic fatty liver disease
-
Pagadala M., Kasumov T., McCullough A.J., Zein N.N., Kirwan J.P. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol. Metab. 2012, 23:365-371.
-
(2012)
Trends Endocrinol. Metab.
, vol.23
, pp. 365-371
-
-
Pagadala, M.1
Kasumov, T.2
McCullough, A.J.3
Zein, N.N.4
Kirwan, J.P.5
-
54
-
-
0035126796
-
Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells
-
Chen C.C., Sun Y.T., Chen J.J., Chang Y.J. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. Mol. Pharmacol. 2001, 59:493-500.
-
(2001)
Mol. Pharmacol.
, vol.59
, pp. 493-500
-
-
Chen, C.C.1
Sun, Y.T.2
Chen, J.J.3
Chang, Y.J.4
-
55
-
-
60149098492
-
The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells
-
Li D.D., Wang L.L., Deng R., Tang J., Shen Y., Guo J.F., Wang Y., Xia L.P., Feng G.K., Liu Q.Q., Huang W.L., Zeng Y.X., Zhu X.F. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009, 28:886-898.
-
(2009)
Oncogene
, vol.28
, pp. 886-898
-
-
Li, D.D.1
Wang, L.L.2
Deng, R.3
Tang, J.4
Shen, Y.5
Guo, J.F.6
Wang, Y.7
Xia, L.P.8
Feng, G.K.9
Liu, Q.Q.10
Huang, W.L.11
Zeng, Y.X.12
Zhu, X.F.13
-
56
-
-
84891922939
-
Ceramides and glucosylceramides are independent antagonists of insulin signaling
-
Chavez J.A., Siddique M.M., Wang S.T., Ching J., Shayman J.A., Summers S.A. Ceramides and glucosylceramides are independent antagonists of insulin signaling. J. Biol. Chem. 2014, 289:723-734.
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 723-734
-
-
Chavez, J.A.1
Siddique, M.M.2
Wang, S.T.3
Ching, J.4
Shayman, J.A.5
Summers, S.A.6
-
57
-
-
77951433803
-
Hepatic glycosphingolipid deficiency and liver function in mice
-
Jennemann R., Rothermel U., Wang S., Sandhoff R., Kaden S., Out R., van Berkel T.J., Aerts J.M., Ghauharali K., Sticht C., Grone H.J. Hepatic glycosphingolipid deficiency and liver function in mice. Hepatology 2010, 51:1799-1809.
-
(2010)
Hepatology
, vol.51
, pp. 1799-1809
-
-
Jennemann, R.1
Rothermel, U.2
Wang, S.3
Sandhoff, R.4
Kaden, S.5
Out, R.6
van Berkel, T.J.7
Aerts, J.M.8
Ghauharali, K.9
Sticht, C.10
Grone, H.J.11
-
58
-
-
0022243876
-
The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols
-
Boni L.T., Rando R.R. The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols. J. Biol. Chem. 1985, 260:10819-10825.
-
(1985)
J. Biol. Chem.
, vol.260
, pp. 10819-10825
-
-
Boni, L.T.1
Rando, R.R.2
-
59
-
-
84860497397
-
Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance
-
Jornayvaz F.R., Shulman G.I. Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab. 2012, 15:574-584.
-
(2012)
Cell Metab.
, vol.15
, pp. 574-584
-
-
Jornayvaz, F.R.1
Shulman, G.I.2
-
60
-
-
84881098074
-
Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo
-
Galbo T., Perry R.J., Jurczak M.J., Camporez J.P., Alves T.C., Kahn M., Guigni B.A., Serr J., Zhang D., Bhanot S., Samuel V.T., Shulman G.I. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:12780-12785.
-
(2013)
Proc. Natl. Acad. Sci. U. S. A.
, vol.110
, pp. 12780-12785
-
-
Galbo, T.1
Perry, R.J.2
Jurczak, M.J.3
Camporez, J.P.4
Alves, T.C.5
Kahn, M.6
Guigni, B.A.7
Serr, J.8
Zhang, D.9
Bhanot, S.10
Samuel, V.T.11
Shulman, G.I.12
-
61
-
-
33847404482
-
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease
-
Samuel V.T., Liu Z.X., Wang A., Beddow S.A., Geisler J.G., Kahn M., Zhang X.M., Monia B.P., Bhanot S., Shulman G.I. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 2007, 117:739-745.
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 739-745
-
-
Samuel, V.T.1
Liu, Z.X.2
Wang, A.3
Beddow, S.A.4
Geisler, J.G.5
Kahn, M.6
Zhang, X.M.7
Monia, B.P.8
Bhanot, S.9
Shulman, G.I.10
-
62
-
-
33750584214
-
TLR4 links innate immunity and fatty acid-induced insulin resistance
-
Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 3015-3025
-
-
Shi, H.1
Kokoeva, M.V.2
Inouye, K.3
Tzameli, I.4
Yin, H.5
Flier, J.S.6
-
63
-
-
36349024819
-
A lipidomic analysis of nonalcoholic fatty liver disease
-
Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., Sargeant C., Contos M.J., Sanyal A.J. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46:1081-1090.
-
(2007)
Hepatology
, vol.46
, pp. 1081-1090
-
-
Puri, P.1
Baillie, R.A.2
Wiest, M.M.3
Mirshahi, F.4
Choudhury, J.5
Cheung, O.6
Sargeant, C.7
Contos, M.J.8
Sanyal, A.J.9
-
64
-
-
84873178604
-
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
-
Cantley J.L., Yoshimura T., Camporez J.P., Zhang D., Jornayvaz F.R., Kumashiro N., Guebre-Egziabher F., Jurczak M.J., Kahn M., Guigni B.A., Serr J., Hankin J., Murphy R.C., Cline G.W., Bhanot S., Manchem V.P., Brown J.M., Samuel V.T., Shulman G.I. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1869-1874.
-
(2013)
Proc. Natl. Acad. Sci. U. S. A.
, vol.110
, pp. 1869-1874
-
-
Cantley, J.L.1
Yoshimura, T.2
Camporez, J.P.3
Zhang, D.4
Jornayvaz, F.R.5
Kumashiro, N.6
Guebre-Egziabher, F.7
Jurczak, M.J.8
Kahn, M.9
Guigni, B.A.10
Serr, J.11
Hankin, J.12
Murphy, R.C.13
Cline, G.W.14
Bhanot, S.15
Manchem, V.P.16
Brown, J.M.17
Samuel, V.T.18
Shulman, G.I.19
-
65
-
-
84899560268
-
Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation
-
Liang W., Lindeman J.H., Menke A.L., Koonen D.P., Morrison M., Havekes L.M., van den Hoek A.M., Kleemann R. Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation. Lab. Investig. 2014, 94:491-502.
-
(2014)
Lab. Investig.
, vol.94
, pp. 491-502
-
-
Liang, W.1
Lindeman, J.H.2
Menke, A.L.3
Koonen, D.P.4
Morrison, M.5
Havekes, L.M.6
van den Hoek, A.M.7
Kleemann, R.8
-
66
-
-
0346880505
-
Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance
-
Shoelson S.E., Lee J., Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord. 2003, 27(Suppl. 3):S49-S52.
-
(2003)
Int. J. Obes. Relat. Metab. Disord.
, vol.27
, pp. S49-S52
-
-
Shoelson, S.E.1
Lee, J.2
Yuan, M.3
-
67
-
-
0034746919
-
NF-kappaB: a key role in inflammatory diseases
-
Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
-
(2001)
J. Clin. Invest.
, vol.107
, pp. 7-11
-
-
Tak, P.P.1
Firestein, G.S.2
-
68
-
-
14644427890
-
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB
-
Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 2005, 11:183-190.
-
(2005)
Nat. Med.
, vol.11
, pp. 183-190
-
-
Cai, D.1
Yuan, M.2
Frantz, D.F.3
Melendez, P.A.4
Hansen, L.5
Lee, J.6
Shoelson, S.E.7
-
69
-
-
20044387026
-
IKK-beta links inflammation to obesity-induced insulin resistance
-
Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11:191-198.
-
(2005)
Nat. Med.
, vol.11
, pp. 191-198
-
-
Arkan, M.C.1
Hevener, A.L.2
Greten, F.R.3
Maeda, S.4
Li, Z.W.5
Long, J.M.6
Wynshaw-Boris, A.7
Poli, G.8
Olefsky, J.9
Karin, M.10
-
70
-
-
0028237775
-
Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family
-
Hultmark D. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 1994, 199:144-146.
-
(1994)
Biochem. Biophys. Res. Commun.
, vol.199
, pp. 144-146
-
-
Hultmark, D.1
-
71
-
-
77953891627
-
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice
-
Miura K., Kodama Y., Inokuchi S., Schnabl B., Aoyama T., Ohnishi H., Olefsky J.M., Brenner D.A., Seki E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 2010, 139:323-334.
-
(2010)
Gastroenterology
, vol.139
, pp. 323-334
-
-
Miura, K.1
Kodama, Y.2
Inokuchi, S.3
Schnabl, B.4
Aoyama, T.5
Ohnishi, H.6
Olefsky, J.M.7
Brenner, D.A.8
Seki, E.9
-
72
-
-
79953653547
-
Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse
-
Kuo L.H., Tsai P.J., Jiang M.J., Chuang Y.L., Yu L., Lai K.T., Tsai Y.S. Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia 2011, 54:168-179.
-
(2011)
Diabetologia
, vol.54
, pp. 168-179
-
-
Kuo, L.H.1
Tsai, P.J.2
Jiang, M.J.3
Chuang, Y.L.4
Yu, L.5
Lai, K.T.6
Tsai, Y.S.7
-
73
-
-
77958536355
-
Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice
-
Hosoi T., Yokoyama S., Matsuo S., Akira S., Ozawa K. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS ONE 2010, 5:e12537.
-
(2010)
PLoS ONE
, vol.5
, pp. e12537
-
-
Hosoi, T.1
Yokoyama, S.2
Matsuo, S.3
Akira, S.4
Ozawa, K.5
-
74
-
-
0037073679
-
Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex
-
Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 2002, 277:48115-48121.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 48115-48121
-
-
Gao, Z.1
Hwang, D.2
Bataille, F.3
Lefevre, M.4
York, D.5
Quon, M.J.6
Ye, J.7
-
75
-
-
0042591261
-
Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases
-
Gao Z., Zuberi A., Quon M.J., Dong Z., Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J. Biol. Chem. 2003, 278:24944-24950.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 24944-24950
-
-
Gao, Z.1
Zuberi, A.2
Quon, M.J.3
Dong, Z.4
Ye, J.5
-
76
-
-
0030669094
-
Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612
-
De Fea K., Roth R.A. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 1997, 36:12939-12947.
-
(1997)
Biochemistry
, vol.36
, pp. 12939-12947
-
-
De Fea, K.1
Roth, R.A.2
-
77
-
-
0037059330
-
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action
-
Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 2002, 277:1531-1537.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 1531-1537
-
-
Aguirre, V.1
Werner, E.D.2
Giraud, J.3
Lee, Y.H.4
Shoelson, S.E.5
White, M.F.6
-
78
-
-
33845947091
-
Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice
-
Tamura Y., Ogihara T., Uchida T., Ikeda F., Kumashiro N., Nomiyama T., Sato F., Hirose T., Tanaka Y., Mochizuki H., Kawamori R., Watada H. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice. Diabetologia 2007, 50:131-141.
-
(2007)
Diabetologia
, vol.50
, pp. 131-141
-
-
Tamura, Y.1
Ogihara, T.2
Uchida, T.3
Ikeda, F.4
Kumashiro, N.5
Nomiyama, T.6
Sato, F.7
Hirose, T.8
Tanaka, Y.9
Mochizuki, H.10
Kawamori, R.11
Watada, H.12
-
79
-
-
82955233198
-
Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events
-
Verhelst K., Carpentier I., Beyaert R. Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events. Cytokine Growth Factor Rev. 2011, 22:277-286.
-
(2011)
Cytokine Growth Factor Rev.
, vol.22
, pp. 277-286
-
-
Verhelst, K.1
Carpentier, I.2
Beyaert, R.3
-
80
-
-
73649094118
-
Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis
-
Romanatto T., Roman E.A., Arruda A.P., Denis R.G., Solon C., Milanski M., Moraes J.C., Bonfleur M.L., Degasperi G.R., Picardi P.K., Hirabara S., Boschero A.C., Curi R., Velloso L.A. Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J. Biol. Chem. 2009, 284:36213-36222.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 36213-36222
-
-
Romanatto, T.1
Roman, E.A.2
Arruda, A.P.3
Denis, R.G.4
Solon, C.5
Milanski, M.6
Moraes, J.C.7
Bonfleur, M.L.8
Degasperi, G.R.9
Picardi, P.K.10
Hirabara, S.11
Boschero, A.C.12
Curi, R.13
Velloso, L.A.14
-
81
-
-
0030756346
-
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
-
Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
-
(1997)
Nature
, vol.389
, pp. 610-614
-
-
Uysal, K.T.1
Wiesbrock, S.M.2
Marino, M.W.3
Hotamisligil, G.S.4
-
82
-
-
0032528177
-
Obesity and diabetes in TNF-alpha receptor-deficient mice
-
Schreyer S.A., Chua S.C., LeBoeuf R.C. Obesity and diabetes in TNF-alpha receptor-deficient mice. J. Clin. Invest. 1998, 102:402-411.
-
(1998)
J. Clin. Invest.
, vol.102
, pp. 402-411
-
-
Schreyer, S.A.1
Chua, S.C.2
LeBoeuf, R.C.3
-
83
-
-
77950630410
-
Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice
-
Toda K., Hayashi Y., Saibara T. Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice. Biochim. Biophys. Acta 2010, 1801:655-664.
-
(2010)
Biochim. Biophys. Acta
, vol.1801
, pp. 655-664
-
-
Toda, K.1
Hayashi, Y.2
Saibara, T.3
-
84
-
-
84873310784
-
Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model
-
Aparicio-Vergara M., Hommelberg P.P., Schreurs M., Gruben N., Stienstra R., Shiri-Sverdlov R., Kloosterhuis N.J., de Bruin A., van de Sluis B., Koonen D.P., Hofker M.H. Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Hepatology 2013, 57:566-576.
-
(2013)
Hepatology
, vol.57
, pp. 566-576
-
-
Aparicio-Vergara, M.1
Hommelberg, P.P.2
Schreurs, M.3
Gruben, N.4
Stienstra, R.5
Shiri-Sverdlov, R.6
Kloosterhuis, N.J.7
de Bruin, A.8
van de Sluis, B.9
Koonen, D.P.10
Hofker, M.H.11
-
85
-
-
84863161186
-
Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses
-
Chen Z., Sheng L., Shen H., Zhao Y., Wang S., Brink R., Rui L. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes 2012, 61:566-573.
-
(2012)
Diabetes
, vol.61
, pp. 566-573
-
-
Chen, Z.1
Sheng, L.2
Shen, H.3
Zhao, Y.4
Wang, S.5
Brink, R.6
Rui, L.7
-
86
-
-
0035896422
-
Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice
-
Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., Schreiber R.D. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 2001, 291:2162-2165.
-
(2001)
Science
, vol.291
, pp. 2162-2165
-
-
Yin, L.1
Wu, L.2
Wesche, H.3
Arthur, C.D.4
White, J.M.5
Goeddel, D.V.6
Schreiber, R.D.7
-
87
-
-
84862000588
-
NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
-
Sheng L., Zhou Y., Chen Z., Ren D., Cho K.W., Jiang L., Shen H., Sasaki Y., Rui L. NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat. Med. 2012, 18:943-949.
-
(2012)
Nat. Med.
, vol.18
, pp. 943-949
-
-
Sheng, L.1
Zhou, Y.2
Chen, Z.3
Ren, D.4
Cho, K.W.5
Jiang, L.6
Shen, H.7
Sasaki, Y.8
Rui, L.9
-
88
-
-
0030714605
-
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
-
Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175-179.
-
(1997)
Nature
, vol.390
, pp. 175-179
-
-
Anderson, D.M.1
Maraskovsky, E.2
Billingsley, W.L.3
Dougall, W.C.4
Tometsko, M.E.5
Roux, E.R.6
Teepe, M.C.7
DuBose, R.F.8
Cosman, D.9
Galibert, L.10
-
89
-
-
84875221877
-
Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
-
Kiechl S., Wittmann J., Giaccari A., Knoflach M., Willeit P., Bozec A., Moschen A.R., Muscogiuri G., Sorice G.P., Kireva T., Summerer M., Wirtz S., Luther J., Mielenz D., Billmeier U., Egger G., Mayr A., Oberhollenzer F., Kronenberg F., Orthofer M., Penninger J.M., Meigs J.B., Bonora E., Tilg H., Willeit J., Schett G. Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat. Med. 2013, 19:358-363.
-
(2013)
Nat. Med.
, vol.19
, pp. 358-363
-
-
Kiechl, S.1
Wittmann, J.2
Giaccari, A.3
Knoflach, M.4
Willeit, P.5
Bozec, A.6
Moschen, A.R.7
Muscogiuri, G.8
Sorice, G.P.9
Kireva, T.10
Summerer, M.11
Wirtz, S.12
Luther, J.13
Mielenz, D.14
Billmeier, U.15
Egger, G.16
Mayr, A.17
Oberhollenzer, F.18
Kronenberg, F.19
Orthofer, M.20
Penninger, J.M.21
Meigs, J.B.22
Bonora, E.23
Tilg, H.24
Willeit, J.25
Schett, G.26
more..
-
90
-
-
84864198388
-
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches
-
Seki E., Brenner D.A., Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012, 143:307-320.
-
(2012)
Gastroenterology
, vol.143
, pp. 307-320
-
-
Seki, E.1
Brenner, D.A.2
Karin, M.3
-
91
-
-
8544244943
-
Modulation of the JNK pathway in liver affects insulin resistance status
-
Nakatani Y., Kaneto H., Kawamori D., Hatazaki M., Miyatsuka T., Matsuoka T.A., Kajimoto Y., Matsuhisa M., Yamasaki Y., Hori M. Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem. 2004, 279:45803-45809.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 45803-45809
-
-
Nakatani, Y.1
Kaneto, H.2
Kawamori, D.3
Hatazaki, M.4
Miyatsuka, T.5
Matsuoka, T.A.6
Kajimoto, Y.7
Matsuhisa, M.8
Yamasaki, Y.9
Hori, M.10
-
92
-
-
34547942526
-
Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice
-
Yang R., Wilcox D.M., Haasch D.L., Jung P.M., Nguyen P.T., Voorbach M.J., Doktor S., Brodjian S., Bush E.N., Lin E., Jacobson P.B., Collins C.A., Landschulz K.T., Trevillyan J.M., Rondinone C.M., Surowy T.K. Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice. J. Biol. Chem. 2007, 282:22765-22774.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 22765-22774
-
-
Yang, R.1
Wilcox, D.M.2
Haasch, D.L.3
Jung, P.M.4
Nguyen, P.T.5
Voorbach, M.J.6
Doktor, S.7
Brodjian, S.8
Bush, E.N.9
Lin, E.10
Jacobson, P.B.11
Collins, C.A.12
Landschulz, K.T.13
Trevillyan, J.M.14
Rondinone, C.M.15
Surowy, T.K.16
-
93
-
-
33750823407
-
Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates
-
Solinas G., Naugler W., Galimi F., Lee M.S., Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16454-16459.
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.103
, pp. 16454-16459
-
-
Solinas, G.1
Naugler, W.2
Galimi, F.3
Lee, M.S.4
Karin, M.5
-
94
-
-
70449927269
-
Prevention of steatosis by hepatic JNK1
-
Sabio G., Cavanagh-Kyros J., Ko H.J., Jung D.Y., Gray S., Jun J.Y., Barrett T., Mora A., Kim J.K., Davis R.J. Prevention of steatosis by hepatic JNK1. Cell Metab. 2009, 10:491-498.
-
(2009)
Cell Metab.
, vol.10
, pp. 491-498
-
-
Sabio, G.1
Cavanagh-Kyros, J.2
Ko, H.J.3
Jung, D.Y.4
Gray, S.5
Jun, J.Y.6
Barrett, T.7
Mora, A.8
Kim, J.K.9
Davis, R.J.10
-
95
-
-
67349205002
-
Kupffer cells in non-alcoholic fatty liver disease: the emerging view
-
Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J. Hepatol. 2009, 51:212-223.
-
(2009)
J. Hepatol.
, vol.51
, pp. 212-223
-
-
Baffy, G.1
-
96
-
-
77449117735
-
Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance
-
Huang W., Metlakunta A., Dedousis N., Zhang P., Sipula I., Dube J.J., Scott D.K., O'Doherty R.M. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010, 59:347-357.
-
(2010)
Diabetes
, vol.59
, pp. 347-357
-
-
Huang, W.1
Metlakunta, A.2
Dedousis, N.3
Zhang, P.4
Sipula, I.5
Dube, J.J.6
Scott, D.K.7
O'Doherty, R.M.8
-
97
-
-
73549090090
-
Kupffer cell activation is a causal factor for hepatic insulin resistance
-
Lanthier N., Molendi-Coste O., Horsmans Y., van Rooijen N., Cani P.D., Leclercq I.A. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G107-G116.
-
(2010)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.298
, pp. G107-G116
-
-
Lanthier, N.1
Molendi-Coste, O.2
Horsmans, Y.3
van Rooijen, N.4
Cani, P.D.5
Leclercq, I.A.6
-
98
-
-
67349130130
-
Critical role of Kupffer cells in the management of diet-induced diabetes and obesity
-
Neyrinck A.M., Cani P.D., Dewulf E.M., De Backer F., Bindels L.B., Delzenne N.M. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem. Biophys. Res. Commun. 2009, 385:351-356.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.385
, pp. 351-356
-
-
Neyrinck, A.M.1
Cani, P.D.2
Dewulf, E.M.3
De Backer, F.4
Bindels, L.B.5
Delzenne, N.M.6
-
99
-
-
79959736389
-
Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis
-
Henkel J., Gartner D., Dorn C., Hellerbrand C., Schanze N., Elz S.R., Puschel G.P. Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis. Lab. Investig. 2011, 91:1107-1117.
-
(2011)
Lab. Investig.
, vol.91
, pp. 1107-1117
-
-
Henkel, J.1
Gartner, D.2
Dorn, C.3
Hellerbrand, C.4
Schanze, N.5
Elz, S.R.6
Puschel, G.P.7
-
100
-
-
84858710276
-
Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages
-
Papackova Z., Palenickova E., Dankova H., Zdychova J., Skop V., Kazdova L., Cahova M. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages. Nutr. Metab. (Lond.) 2012, 9:22.
-
(2012)
Nutr. Metab. (Lond.)
, vol.9
, pp. 22
-
-
Papackova, Z.1
Palenickova, E.2
Dankova, H.3
Zdychova, J.4
Skop, V.5
Kazdova, L.6
Cahova, M.7
-
101
-
-
73349127065
-
Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling
-
Clementi A.H., Gaudy A.M., van Rooijen N., Pierce R.H., Mooney R.A. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim. Biophys. Acta 2009, 1792:1062-1072.
-
(2009)
Biochim. Biophys. Acta
, vol.1792
, pp. 1062-1072
-
-
Clementi, A.H.1
Gaudy, A.M.2
van Rooijen, N.3
Pierce, R.H.4
Mooney, R.A.5
-
102
-
-
82655181355
-
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet
-
Lanthier N., Molendi-Coste O., Cani P.D., van Rooijen N., Horsmans Y., Leclercq I.A. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J. 2011, 25:4301-4311.
-
(2011)
FASEB J.
, vol.25
, pp. 4301-4311
-
-
Lanthier, N.1
Molendi-Coste, O.2
Cani, P.D.3
van Rooijen, N.4
Horsmans, Y.5
Leclercq, I.A.6
-
103
-
-
44349161098
-
Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance
-
Odegaard J.I., Ricardo-Gonzalez R.R., Red Eagle A., Vats D., Morel C.R., Goforth M.H., Subramanian V., Mukundan L., Ferrante A.W., Chawla A. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008, 7:496-507.
-
(2008)
Cell Metab.
, vol.7
, pp. 496-507
-
-
Odegaard, J.I.1
Ricardo-Gonzalez, R.R.2
Red Eagle, A.3
Vats, D.4
Morel, C.R.5
Goforth, M.H.6
Subramanian, V.7
Mukundan, L.8
Ferrante, A.W.9
Chawla, A.10
-
104
-
-
77956335194
-
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action
-
Wunderlich F.T., Strohle P., Konner A.C., Gruber S., Tovar S., Bronneke H.S., Juntti-Berggren L., Li L.S., van Rooijen N., Libert C., Berggren P.O., Bruning J.C. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab. 2010, 12:237-249.
-
(2010)
Cell Metab.
, vol.12
, pp. 237-249
-
-
Wunderlich, F.T.1
Strohle, P.2
Konner, A.C.3
Gruber, S.4
Tovar, S.5
Bronneke, H.S.6
Juntti-Berggren, L.7
Li, L.S.8
van Rooijen, N.9
Libert, C.10
Berggren, P.O.11
Bruning, J.C.12
-
105
-
-
80755168919
-
Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding
-
Tateya S., Rizzo N.O., Handa P., Cheng A.M., Morgan-Stevenson V., Daum G., Clowes A.W., Morton G.J., Schwartz M.W., Kim F. Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes 2011, 60:2792-2801.
-
(2011)
Diabetes
, vol.60
, pp. 2792-2801
-
-
Tateya, S.1
Rizzo, N.O.2
Handa, P.3
Cheng, A.M.4
Morgan-Stevenson, V.5
Daum, G.6
Clowes, A.W.7
Morton, G.J.8
Schwartz, M.W.9
Kim, F.10
-
106
-
-
84892872444
-
Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice
-
Funke A., Schreurs M., Aparicio-Vergara M., Sheedfar F., Gruben N., Kloosterhuis N.J., Shiri-Sverdlov R., Groen A.K., van de Sluis B., Hofker M.H., Koonen D.P. Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice. Atherosclerosis 2014, 232:390-396.
-
(2014)
Atherosclerosis
, vol.232
, pp. 390-396
-
-
Funke, A.1
Schreurs, M.2
Aparicio-Vergara, M.3
Sheedfar, F.4
Gruben, N.5
Kloosterhuis, N.J.6
Shiri-Sverdlov, R.7
Groen, A.K.8
van de Sluis, B.9
Hofker, M.H.10
Koonen, D.P.11
-
107
-
-
49649110937
-
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
-
Wouters K., van Gorp P.J., Bieghs V., Gijbels M.J., Duimel H., Lutjohann D., Kerksiek A., van Kruchten R., Maeda N., Staels B., van Bilsen M., Shiri-Sverdlov R., Hofker M.H. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008, 48:474-486.
-
(2008)
Hepatology
, vol.48
, pp. 474-486
-
-
Wouters, K.1
van Gorp, P.J.2
Bieghs, V.3
Gijbels, M.J.4
Duimel, H.5
Lutjohann, D.6
Kerksiek, A.7
van Kruchten, R.8
Maeda, N.9
Staels, B.10
van Bilsen, M.11
Shiri-Sverdlov, R.12
Hofker, M.H.13
-
108
-
-
84856297712
-
LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease
-
Bieghs V., Van Gorp P.J., Wouters K., Hendrikx T., Gijbels M.J., van Bilsen M., Bakker J., Binder C.J., Lutjohann D., Staels B., Hofker M.H., Shiri-Sverdlov R. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS ONE 2012, 7:e30668.
-
(2012)
PLoS ONE
, vol.7
, pp. e30668
-
-
Bieghs, V.1
Van Gorp, P.J.2
Wouters, K.3
Hendrikx, T.4
Gijbels, M.J.5
van Bilsen, M.6
Bakker, J.7
Binder, C.J.8
Lutjohann, D.9
Staels, B.10
Hofker, M.H.11
Shiri-Sverdlov, R.12
-
109
-
-
71149086343
-
Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis
-
Rensen S.S., Slaats Y., Nijhuis J., Jans A., Bieghs V., Driessen A., Malle E., Greve J.W., Buurman W.A. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am. J. Pathol. 2009, 175:1473-1482.
-
(2009)
Am. J. Pathol.
, vol.175
, pp. 1473-1482
-
-
Rensen, S.S.1
Slaats, Y.2
Nijhuis, J.3
Jans, A.4
Bieghs, V.5
Driessen, A.6
Malle, E.7
Greve, J.W.8
Buurman, W.A.9
-
110
-
-
84868671526
-
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
-
Talukdar S., Oh da Y., Bandyopadhyay G., Li D., Xu J., McNelis J., Lu M., Li P., Yan Q., Zhu Y., Ofrecio J., Lin M., Brenner M.B., Olefsky J.M. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012, 18:1407-1412.
-
(2012)
Nat. Med.
, vol.18
, pp. 1407-1412
-
-
Talukdar, S.1
Oh da, Y.2
Bandyopadhyay, G.3
Li, D.4
Xu, J.5
McNelis, J.6
Lu, M.7
Li, P.8
Yan, Q.9
Zhu, Y.10
Ofrecio, J.11
Lin, M.12
Brenner, M.B.13
Olefsky, J.M.14
-
111
-
-
77953525682
-
Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease
-
Hua J., Ma X., Webb T., Potter J.J., Oelke M., Li Z. Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. J. Lipid Res. 2010, 51:1696-1703.
-
(2010)
J. Lipid Res.
, vol.51
, pp. 1696-1703
-
-
Hua, J.1
Ma, X.2
Webb, T.3
Potter, J.J.4
Oelke, M.5
Li, Z.6
-
112
-
-
84907974271
-
Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding
-
Martin-Murphy B.V., You Q., Wang H., De La Houssaye B.A., Reilly T.P., Friedman J.E., Ju C. Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding. PLoS ONE 2014, 9:e80949.
-
(2014)
PLoS ONE
, vol.9
, pp. e80949
-
-
Martin-Murphy, B.V.1
You, Q.2
Wang, H.3
De La Houssaye, B.A.4
Reilly, T.P.5
Friedman, J.E.6
Ju, C.7
|